stockportfolio.pro
Integra LifeSciences Holdings Corporation Total Debt 2008–2025
Integra LifeSciences Holdings Corporation (IART) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $726.56M | -4.5% |
| FY 2024 | $760.47M | -1.9% |
| FY 2023 | $775.00M | +0.0% |
| FY 2022 | $775.00M | -8.1% |
| FY 2021 | $843.75M | -3.8% |
| FY 2020 | $877.50M | +0.0% |
| FY 2019 | $877.50M | -2.5% |
| FY 2018 | $900.00M | — |
| FY 2017 | $0 | — |
| FY 2016 | $0 | — |
| FY 2015 | $0 | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | — |
| FY 2010 | $0 | — |
| FY 2009 | $0 | — |
| FY 2008 | $0 | — |
Source: Integra LifeSciences Holdings Corporation SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated June 15, 2026). Methodology.
See the full picture for Integra LifeSciences Holdings Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIntegra LifeSciences Holdings Corporation — frequently asked questions
What is Integra LifeSciences Holdings Corporation's total debt (short- plus long-term borrowings)?
Integra LifeSciences Holdings Corporation (IART) reported total debt (short- plus long-term borrowings) of $726.56M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Integra LifeSciences Holdings Corporation's official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.